These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2992298

  • 1. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome.
    Haskett RF.
    Am J Psychiatry; 1985 Aug; 142(8):911-6. PubMed ID: 2992298
    [Abstract] [Full Text] [Related]

  • 2. Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.
    Starkman MN, Schteingart DE.
    Arch Intern Med; 1981 Feb; 141(2):215-9. PubMed ID: 6257194
    [Abstract] [Full Text] [Related]

  • 3. Phenomenology and family history of affective disorder in Cushing's disease.
    Hudson JI, Hudson MS, Griffing GT, Melby JC, Pope HG.
    Am J Psychiatry; 1987 Jul; 144(7):951-3. PubMed ID: 3605410
    [Abstract] [Full Text] [Related]

  • 4. Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder.
    Krystal A, Krishnan KR, Raitiere M, Poland R, Ritchie JC, Dunnick NR, Hanada K, Nemeroff CB.
    J Neuropsychiatry Clin Neurosci; 1990 Jul; 2(1):34-43. PubMed ID: 1967010
    [Abstract] [Full Text] [Related]

  • 5. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels.
    Starkman MN, Schteingart DE, Schork MA.
    Psychosom Med; 1981 Feb; 43(1):3-18. PubMed ID: 6259680
    [Abstract] [Full Text] [Related]

  • 6. A prospective study of psychiatric and psychological aspects of Cushing's syndrome.
    Kelly WF, Kelly MJ, Faragher B.
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):715-20. PubMed ID: 9039337
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [Abstract] [Full Text] [Related]

  • 8. Mania in Cushing's syndrome: case report.
    Reed K, Watkins M, Dobson H.
    J Clin Psychiatry; 1983 Dec; 44(12):460-2. PubMed ID: 6317660
    [Abstract] [Full Text] [Related]

  • 9. Psychiatric phenomenology in Cushing's disease.
    Loosen PT, Chambliss B, DeBold CR, Shelton R, Orth DN.
    Pharmacopsychiatry; 1992 Jul; 25(4):192-8. PubMed ID: 1528959
    [Abstract] [Full Text] [Related]

  • 10. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [Abstract] [Full Text] [Related]

  • 11. Psychiatric disorders associated with Cushing's syndrome.
    Bratek A, Koźmin-Burzyńska A, Górniak E, Krysta K.
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S339-43. PubMed ID: 26417792
    [Abstract] [Full Text] [Related]

  • 12. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S, Van Cauter E, Fang VS, Laderman C, Graybeal ML, Landau RL.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [Abstract] [Full Text] [Related]

  • 13. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol.
    Jeffcoate WJ, Silverstone JT, Edwards CR, Besser GM.
    Q J Med; 1979 Jul; 48(191):465-72. PubMed ID: 542586
    [Abstract] [Full Text] [Related]

  • 14. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F.
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC, Raff H, Findling JW.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [Abstract] [Full Text] [Related]

  • 16. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G, DeBold CR, Gaitan D, DeCherney GS, Jackson RV, Sheldon WR, Nicholson WE, Orth DN.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [Abstract] [Full Text] [Related]

  • 18. Affective disorders and endocrine disease. New insights from psychosomatic studies.
    Fava GA.
    Psychosomatics; 1994 Feb; 35(4):341-53. PubMed ID: 8084985
    [Abstract] [Full Text] [Related]

  • 19. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O, Jørgensen H, Frey H, Norman N.
    Tidsskr Nor Laegeforen; 1989 Sep 20; 109(26):2678-82. PubMed ID: 2554527
    [Abstract] [Full Text] [Related]

  • 20. Depression and Cushing's syndrome.
    Lancet; 1986 Sep 06; 2(8506):550-1. PubMed ID: 2875285
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.